Delivery Order SPE2DB20D7066-SPE2DB26FC1NS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Nitroglycerin 0.4% Ointment in 30-gram units, with a ceiling value of $3,509.00. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The order is expected to be completed by October 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Nitroglycerin 0.4% Ointment in 30-gram quantities, with a ceiling value of $4,833.83. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of June 2, 2025. As a child contract action, this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Nitroglycerin 0.4% Ointment in 30-gram units. This competitively awarded, non-set-aside contract carries a ceiling value of $7,656.59 and is structured as a firm fixed-price delivery order with a completion date of September 24, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,700.17 delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Nitroglycerin 0.4% Ointment in 30-gram units. This is a firm fixed-price contract with an ultimate completion date of November 3, 2025, and represents a non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nitroglycerin 0.4% Ointment in 30-gram quantities under a firm fixed-price contract valued at $1,001.74. The order was competitively awarded without set-aside designation and is scheduled for completion by April 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this delivery order, which represents a child contract under a larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,302.68 for Nitroglycerin 0.4% Ointment in 30-gram units on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under a larger indefinite delivery vehicle. The product will be performed and delivered from AmerisourceBergen's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Nitroglycerin 0.4% Ointment in 30-gram quantities, with a contract ceiling value of $1,199.21. This firm fixed-price delivery order, with an ultimate completion date of July 23, 2025, represents a pediatric and geriatric pharmaceutical commodity critical to military and federal healthcare operations. The award is non-set-aside and competitively awarded, reflecting...
- This delivery order, valued at $1,297.30, awards AmerisourceBergen Drug Corp the supply of Nitroglycerin 0.4% Ointment in 30-gram quantities for the Defense Logistics Agency (DLA). The contract utilizes firm fixed-price pricing with an ultimate completion date of July 29, 2025, and was competitively awarded without any set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $4,598.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for Nitroglycerin 0.4% ointment in 30-gram units. This non-set-aside contract, awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a routine pharmaceutical supply delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under a larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,575.91, is for the delivery of Nitroglycerin 0.4% Ointment 30GM, a pharmaceutical product. The contract is not designated as a set-aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about any...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB26FC1NSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,051.53 to AmerisourceBergen Drug Corp for Nitroglycerin 0.4% Ointment in 30-gram units. This contract, which became effective on November 5, 2025, with a completion date of November 6, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award leverages AmerisourceBergen's position as a critical pharmaceutical distributor supporting federal medical procurement needs, with performance of the work occurring at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor agreement enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The nitroglycerin ointment procurement fulfills critical medical supply requirements across the Defense Health Agency and other federal healthcare systems, reflecting the company's extensive portfolio of generic and brand-name medications delivered through competitively awarded federal contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 11/5/25 |